Whitehawk Therapeutics, Inc.
WHWK
$4.28
-$0.12-2.62%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -16.64M | -22.19M | -23.25M | -17.75M | -52.62M |
| Total Depreciation and Amortization | 1.00K | 1.00K | 1.00K | 5.00K | 16.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.16M | 1.85M | 1.56M | 2.18M | 3.09M |
| Change in Net Operating Assets | 949.00K | -1.86M | 4.46M | 185.00K | -3.45M |
| Cash from Operations | -14.53M | -22.21M | -17.23M | -15.38M | -52.96M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -1.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | 0.00 | -70.00K | 0.00 |
| Other Investing Activities | -16.87M | 19.43M | 16.85M | -91.56M | -28.83M |
| Cash from Investing | -16.87M | 19.43M | 16.85M | -91.63M | -28.83M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 87.58M | -- | 25.00K | 0.00 | 29.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.74M | -- | 0.00 | 0.00 | -879.00K |
| Cash from Financing | 81.84M | -- | 25.00K | 0.00 | -850.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 50.44M | -2.78M | -363.00K | -107.01M | -82.63M |